Cargando…
Supplemental (18)F-FDG-PET/CT for Detection of Malignant Transformation of IPMN—A Model-Based Cost-Effectiveness Analysis
SIMPLE SUMMARY: The incidence of IPMN is increasing, mainly attributed to the expanded application of radiological cross-sectional imaging and improvements in image quality. IPMN are the cause of approximately 10% of all pancreatectomies in the USA. A significant number of surgically treated IPMNs d...
Autores principales: | Bicu, Felix, Rink, Johann S., Froelich, Matthias F., Cyran, Clemens C., Rübenthaler, Johannes, Birgin, Emrullah, Röhrich, Manuel, Tollens, Fabian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002963/ https://www.ncbi.nlm.nih.gov/pubmed/33803522 http://dx.doi.org/10.3390/cancers13061365 |
Ejemplares similares
-
(18)F FDG PET/MRI with hepatocyte-specific contrast agent for M staging of rectal cancer: a primary economic evaluation
por: Gassert, Felix G., et al.
Publicado: (2021) -
Cost-Effectiveness of MR-Mammography in Breast Cancer Screening of Women With Extremely Dense Breasts After Two Rounds of Screening
por: Tollens, Fabian, et al.
Publicado: (2021) -
Cost-effectiveness analysis of MRI, CE-CT and 18F-FDG PET/CT for detecting colorectal liver metastases eligible for hepatic resection
por: Schnitzer, Moritz L., et al.
Publicado: (2023) -
Additional MRI for initial M-staging in pancreatic cancer: a cost-effectiveness analysis
por: Gassert, Felix G., et al.
Publicado: (2021) -
Cost-Effectiveness of Digital Breast Tomosynthesis vs. Abbreviated Breast MRI for Screening Women with Intermediate Risk of Breast Cancer—How Low-Cost Must MRI Be?
por: Tollens, Fabian, et al.
Publicado: (2021)